APP and Alzheimer disease: In the first cohort, two brains each were selected to represent control (“control”, without Abeta, and with minimal NFT pathology), early stages of ADNC (“Abeta+”, intermediate-to-high Abeta pathology and minimal NFT pathology), and late stages of ADNC (“AD’’ with advanced Abeta and NFT pathologies) (Table 1).